Company news
23 December 2021 Merry Christmas and Happy New Year! |
23 December 2021 Correction of Postischemic Changes in the Microcirculation of Rat Cerebral Cortex with Mesenchymal Stem CellsAbstract---This study aims at examining how intravenous transplantation of human mesenchymal stem cells (MSCs) performed on the day of ischemia/reperfusion affects the vascular density and the reactivity of the pial arteries and tissue perfusion in the cerebral cortex 7, 14, and 21 days after ischemic exposure. The density of the entire microvascular network and arterial vessels in the pial membrane of the sensorimotor cortex of rats undergoing cerebral |
01 September 2021 Alkor Bio Group of Companies has confirmed its compliance with International Standard ISO 13485:2016During the last week of August Alkor Bio Group of Companies – Russian designer and manufacturer of ELISA, CLIA and PCR diagnostic kits - has been assessed for compliance with the International Standard ISO 13485:2016. |
23 December 2020 Merry Christmas and Happy New Year! |
11 November 2020 Alkor Bio Company LLC registered the third kit for the enzyme immunoassay of antibodies to coronavirusOn October 28, Alkor Bio Company LLC registered the third kit for the enzyme immunoassay of antibodies to coronavirus - cat. No. 200-74 "SARS-CoV-2 ELISA-total antibodies". |
24 September 2020 Alkor Bio Group of Companies has confirmed its compliance with international QMS standard ISO 13485:2016In September of 2020 Alkor Bio Group of Companies – Russian designer and manufacturer of ELISA and PCR diagnostic kits - has been assessed for compliance with the International standard ISO 13485:2016. |